NCT04174937View on ClinicalTrials.gov

PA Tolerability, Safety and Pharmacokinetics in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 17, 2016

Primary Completion Date

May 15, 2019

Study Completion Date

September 15, 2019

Conditions
Infections, Respiratory
Interventions
DRUG

Potentiator of antibiotics (PA)

Intervention is administered to patients in this Arm

OTHER

Placebo PA

Intervention is administered to patients in this Arm

Trial Locations (1)

A05B0H6

Institute Of Cardiology & Internal Diseases, Almaty

All Listed Sponsors
collaborator

Institute Of Cardiology & Internal Diseases, Kazakhstan

OTHER_GOV

collaborator

Al-Farabi Kazakh National University (KazNU)

UNKNOWN

lead

Scientific Center for Anti-infectious Drugs, Kazakhstan

INDUSTRY

NCT04174937 - PA Tolerability, Safety and Pharmacokinetics in Healthy Volunteers | Biotech Hunter | Biotech Hunter